Cell and Gene Therapies
Producing Advanced Therapy Medicinal Products (ATMPs) requires precision, care, and customized environments. At the heart of this process is the gentle handling of sensitive cell materials.
Harro Höfliger, in partnership with the Fraunhofer Institute for Production Technology IPT, brings together scientific expertise and advanced engineering to create fully automated, product-specific solutions. Their goal: to ensure the highest quality in ATMP manufacturing with processes that are efficient, reliable, and designed around the needs of each unique therapy.
Driving Innovation in Gene and Cell Therapy Production
Through a unique collaboration between Fraunhofer IPT and Harro Höfliger, science and industry come together to advance the future of gene and cell therapeutics. With Fraunhofer IPT’s deep expertise in automated cell cultivation and Harro Höfliger’s strength in GMP-compliant machine solutions, the partnership delivers innovative, efficient, and scalable systems for ATMP production.
By combining cutting-edge research with practical engineering, they develop tailored solutions that meet growing industry demands for safety, quality, and efficiency—from lab-scale prototypes to full-scale commercial production.
What You Can Expect:
- End-to-end solutions from research labs to large-scale production
- Faster time to market
- Advanced research from Fraunhofer IPT
- Flexible, modular GMP systems from Harro Höfliger
- Expert support in automation, facility planning, and global service
Together, they help transform breakthrough therapies into real-world treatments.
